Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model

Experimental Cell Research

Volumn 317, Issue 2, 2011, Pages 234-247

  Ke, Xi song ^a,b   Li, Wen cheng ^a,c   Hovland, Randi ^a,b   Qu, Yi ^a   Liu, Run hui ^d   McCormack, Emmet ^b   Thorsen, Frits ^a   Olsen, Jan Roger ^a   Molven, Anders ^a,b   Kogan Sakin, Ira ^e   Rotter, Varda ^e   Akslen, Lars A ^a,b   Oyan, Anne Margrete ^a,b   Kalland, Karl Henning ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Adhesion modules; Cell model; EMT; Malignant features; Prostate

Indexed keywords

BETA CATENIN; BULLOUS PEMPHIGOID ANTIGEN 1; CLAUDIN 1; DESMOGLEIN; GAP JUNCTION PROTEIN; GROWTH FACTOR; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; KERATIN; NECTIN 1; NECTIN 2; NERVE CELL ADHESION MOLECULE; P CADHERIN; TRANSFORMING GROWTH FACTOR BETA2; UVOMORULIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CLONING; CELL DENSITY; CELL INVASION; CELL ISOLATION; CELL JUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; MALE; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; MONOLAYER CULTURE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; TIGHT JUNCTION; WESTERN BLOTTING;

EID: 78649453710     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.10.009     Document Type: Article

References (50)

1. Christiansen J.J., Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006, 66:8319-8326.
2. Gravdal K., Halvorsen O.J., Haukaas S.A., Akslen L.A. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin. Cancer Res. 2007, 13:7003-7011.
3. Kudo-Saito C., Shirako H., Takeuchi T., Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 2009, 15:195-206.
4. Laffin B., Wellberg E., Kwak H.I., Burghardt R.C., Metz R.P., Gustafson T., Schedin P., Porter W.W. Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease 2. Mol. Cell. Biol. 2008, 28:1936-1946.
5. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
6. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
7. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 2008, 14:818-829.
8. Ke X.S., Qu Y., Goldfinger N., Rostad K., Hovland R., Akslen L.A., Rotter V., Oyan A.M., Kalland K.H. Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation. PLoS ONE 2008, 3:1-11.
9. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
10. Smith G.J., Bell W.N., Grisham J.W. Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cells. Cancer Res. 1993, 53:500-508.
11. Rubin H., Xu K. Evidence for the progressive and adaptive nature of spontaneous transformation in the NIH 3T3 cell line. Proc. Natl Acad. Sci. USA 1989, 86:1860-1864.
12. Kogan I., Goldfinger N., Milyavsky M., Cohen M., Shats I., Dobler G., Klocker H., Wasylyk B., Voller M., Aalders T., Schalken J.A., Oren M., Rotter V. hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis. Cancer Res. 2006, 66:3531-3540.
13. Petersen K., Oyan A.M., Rostad K., Olsen S., Bo T.H., Salvesen H.B., Gjertsen B.T., Bruserud O., Halvorsen O.J., Akslen L.A., Steen V.M., Jonassen I., Kalland K.H. Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization. Anal. Biochem. 2007, 366:46-58.
14. Dysvik B., Jonassen I. J-Express: exploring gene expression data using Java. Bioinformatics 2001, 17:369-370.
15. Ke X.S., Qu Y., Rostad K., Li W.C., Lin B., Halvorsen O.J., Haukaas S.A., Jonassen I., Petersen K., Goldfinger N., Rotter V., Akslen L.A., Oyan A.M., Kalland K.H. Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLoS ONE 2009, 4:e4687.
16. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 2005, 102:15545-15550.
17. Coller H.A., Sang L., Roberts J.M. A new description of cellular quiescence. PLoS Biol. 2006, 4:e83.
18. Malumbres M., Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 2001, 1:222-231.
19. Freedman V.H., Shin S.I. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 1974, 3:355-359.
20. Cross M., Dexter T.M. Growth factors in development, transformation, and tumorigenesis. Cell 1991, 64:271-280.
21. Mehlen P., Puisieux A. Metastasis: a question of life or death. Nat. Rev. Cancer 2006, 6:449-458.
22. Letai A. Growth factor withdrawal and apoptosis: the middle game. Mol. Cell 2006, 21:728-730.
23. Naumov G.N., Akslen L.A., Folkman J. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 2006, 5:1779-1787.
24. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 2006, 172:973-981.
25. Beltran M., Puig I., Pena C., Garcia J.M., Alvarez A.B., Pena R., Bonilla F., de Herreros A.G. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev. 2008, 22:756-769.
26. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2000, 2:84-89.
27. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
28. Marie H., Pratt S.J., Betson M., Epple H., Kittler J.T., Meek L., Moss S.J., Troyanovsky S., Attwell D., Longmore G.D., Braga V.M. The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin. J. Biol. Chem. 2003, 278:1220-1228.
29. Bornstein P., Agah A., Kyriakides T.R. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int. J. Biochem. Cell Biol. 2004, 36:1115-1125.
30. Cavallaro U., Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 2004, 4:118-132.
31. Zi X., Guo Y., Simoneau A.R., Hope C., Xie J., Holcombe R.F., Hoang B.H. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res. 2005, 65:9762-9770.
32. American Type Culture Collection Standards Development Organization Workgroup ASN-0002 Cell line misidentification: the beginning of the end. Nat. Rev. Cancer 2010, 10:441-448.
33. Kaighn M.E., Reddel R.R., Lechner J.F., Peehl D.M., Camalier R.F., Brash D.E., Saffiotti U., Harris C.C. Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res. 1989, 49:3050-3056.
34. Kuettel M.R., Thraves P.J., Jung M., Varghese S.P., Prasad S.C., Rhim J.S., Dritschilo A. Radiation-induced neoplastic transformation of human prostate epithelial cells. Cancer Res. 1996, 56:5-10.
35. Rhim J.S., Jin S., Jung M., Thraves P.J., Kuettel M.R., Webber M.M., Hukku B. Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea. Cancer Res. 1997, 57:576-580.
36. Weaver B.A., Cleveland D.W. Does aneuploidy cause cancer?. Curr. Opin. Cell Biol. 2006, 18:658-667.
37. Achanzar W.E., Diwan B.A., Liu J., Quader S.T., Webber M.M., Waalkes M.P. Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res. 2001, 61:455-458.
38. Mondal S., Heidelberger C. In vitro malignant transformation by methylcholanthrene of the progeny of single cells derived from C3H mouse prostate. Proc. Natl Acad. Sci. USA 1970, 65:219-225.
39. Marquardt H., Kuroki T., Huberman E., Selkirk J.K., Heidelberger C., Grover P.L., Sims P. Malignant transformation of cells derived from mouse prostate by epoxides and other derivatives of polycyclic hydrocarbons. Cancer Res. 1972, 32:716-720.
40. Rhim J.S., Webber M.M., Bello D., Lee M.S., Arnstein P., Chen L.S., Jay G. Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc. Natl Acad. Sci. USA 1994, 91:11874-11878.
41. Alonso-Magdalena P., Brossner C., Reiner A., Cheng G., Sugiyama N., Warner M., Gustafsson J.A. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Proc. Natl Acad. Sci. USA 2009, 106:2859-2863.
42. Alcaraz A., Hammerer P., Tubaro A., Schroder F.H., Castro R. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol. 2009, 55:864-873.
43. Husemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., Forni G., Eils R., Fehm T., Riethmuller G., Klein C.A. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68.
44. Podsypanina K., Du Y.C., Jechlinger M., Beverly L.J., Hambardzumyan D., Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 2008, 321:1841-1844.
45. Wellner U., Schubert J., Burk U.C., Schmalhofer O., Zhu F., Sonntag A., Waldvogel B., Vannier C., Darling D. A. zur Hausen, V.G. Brunton, J. Morton, O. Sansom, J. Schuler, M.P. Stemmler, C. Herzberger, U. Hopt, T. Keck, S. Brabletz, T. Brabletz, The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 2009, 11:1487-1495.
46. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
47. Morel A.P., Lievre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008, 3:e2888.
48. Cifone M.A., Fidler I.J. Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. Proc. Natl Acad. Sci. USA 1980, 77:1039-1043.
49. Mori S., Chang J.T., Andrechek E.R., Matsumura N., Baba T., Yao G., Kim J.W., Gatza M., Murphy S., Nevins J.R. Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene 2009, 28:2796-2805.
50. Kath R., Jambrosic J.A., Holland L., Rodeck U., Herlyn M. Development of invasive and growth factor-independent cell variants from primary human melanomas. Cancer Res. 1991, 51:2205-2211.